Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
CASE REPORTS
Nivolumab-induced Vogt-Koyanagi-Harada-like Syndrome and Adrenocortical Insufficiency with Long-term Survival in a Patient with Non-small-cell Lung Cancer
Ryota UshioMasaki YamamotoAtsushi MiyasakaTatsuya MuraokaHiromi KanaokaHironori TamuraAyami KanekoAmi IzawaNobuyuki HiramaShuhei TeranishiSaki ManabeTatsuya InoueKunihiko ShibataYasuyuki SugiuraMakoto KudoTakeshi Kaneko
Author information
JOURNAL OPEN ACCESS

2021 Volume 60 Issue 22 Pages 3593-3598

Details
Abstract

A 58-year-old man was diagnosed with lung adenocarcinoma with a tumor proportion score of 10%. After six cycles of second-line chemotherapy with nivolumab, he achieved a complete response (CR) but developed uveitis and sensorineural hearing disorder, which were consistent with Vogt-Koyanagi-Harada (VKH)-like syndrome. Simultaneously, pituitary adrenocortical insufficiency was identified. Nivolumab discontinuation and systemic corticosteroid administration resolved these immune-related adverse events (irAEs). The patient has maintained a CR without any chemotherapy for approximately two years. We herein report a patient with a long-term progression-free survival despite chemotherapy discontinuation due to irAEs, including VKH-like syndrome, which were appropriately managed.

Content from these authors
© 2021 by The Japanese Society of Internal Medicine
Previous article Next article
feedback
Top